Incidence and risk factors for musculoskeletal adverse effects associated with daptomycin in patients receiving outpatient parenteral antimicrobial therapy

Incidence and risk factors for musculoskeletal adverse effects associated with daptomycin in patients receiving outpatient parenteral antimicrobial therapy

Abstract Background: Daptomycin is preferred in outpatient parenteral antimicrobial therapy (OPAT) due to daily dosing. Elevations in creatine phosphokinase (CPK) of 3%–10% and musculoskeletal adverse events have been described with daptomycin, but data regarding risk factors and frequency of moni...

Full description

Saved in:
Bibliographic Details
Main Authors: Meaghen B. Wiley, Kiya K. Bennett, Emily A. Siegrist, Stephen B. Neely, Joseph Sassine, Bryan P. White
Format: Article
Language:English
Published: Cambridge University Press 2025-01-01
Series:Antimicrobial Stewardship & Healthcare Epidemiology
Online Access:https://www.cambridge.org/core/product/identifier/S2732494X25100879/type/journal_article
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items